Shares of Mid-cap health care company Azenta moved -17.7 this afternoon, and are now trading at $37.0 per share. On the other hand, the average analyst target price for the stock is $None.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.
Azenta investors should be aware of the below:
Azenta has moved -35.6% over the last year.
The company has a price to earnings growth (PEG) ratio of 13.37. A number between 0 and 1 could mean that the market is undervaluing Azenta's estimated growth potential
Its Price to Book (P/B) ratio is 0.83
Azenta currently returns an annual dividend yield of None%.
None
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.
